XNYS
HIMS
Market cap6.26bUSD
Oct 08, Last price
28.06USD
1D
-5.01%
1Q
-18.38%
IPO
182.01%
Name
Hims & Hers Health Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Hims & Hers Health, Inc. operates a comprehensive digital health platform that seamlessly links individuals with licensed medical professionals for virtual consultations and ongoing care. Through its user-friendly websites and mobile app, the company delivers a diverse portfolio of health and wellness solutions directly to consumers. This includes access to recurring prescription medications, alongside a wide selection of over-the-counter drugs, devices, cosmetics, and dietary supplements. Its core focus areas are general wellness, sexual health, skincare, and hair care. Specific non-prescription offerings span categories such as: Wellness: encompassing items like vitamin C, melatonin, biotin, and collagen protein supplements. Skincare: including products such as moisturizers, serums, and face washes. Sexual Health: providing essentials like condoms, climax delay sprays and wipes, vibrators, and lubricants. Hair Care: offering specialized shampoos, conditioners, scalp scrubs, and topical treatments like minoxidil. Beyond direct sales, Hims & Hers also distributes health and wellness products via wholesale partnerships. The company's headquarters are located in San Francisco, California.
Key people
Andrew Dudum
Chairman of the Board, Chief Executive Officer · since 2016
Oluyemi Okupe
Chief Financial Officer · since 2022
Melissa Baird
Chief Operating Officer · since 2018
Nader Kabbani
Chief Operating Officer · since 2025
Mike Chi
Chief Marketing Officer · since 2021
Soleil Boughton
Chief Legal Officer, Corporate Secretary · since 2018
David Wells
Lead Independent Director · since 2023
Patrick Carroll
Director · since 2024
Deb Autor
Independent Director · since 2024
Delos Cosgrove
Independent Director
Independent Director · since 2024
Christopher Payne
Independent Director · since 2024
Christiane Pendarvis
Independent Director · since 2023
Andrea Perez
Independent Director · since 2021
Kare Schultz
Independent Director · since 2024
Legal address
C/O Walkers Corporate Limited.
Cayman Corporate Centre
27 Hospital Road
Grand Cayman
George Town KY1-9008
KY
Cayman Corporate Centre
27 Hospital Road
Grand Cayman
George Town KY1-9008
KY
Headquarters
333 South Grand Avenue
28th Floor
Los Angeles, CA 90071
US
28th Floor
Los Angeles, CA 90071
US
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | |
| Income | ||||||||
Revenues | ||||||||
Cost of revenue | ||||||||
Unusual Expense (Income) | ||||||||
NOPBT | ||||||||
NOPBT Margin | ||||||||
Operating Taxes | ||||||||
Tax Rate | ||||||||
NOPAT | ||||||||
Net income | ||||||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | ||||||||
BB yield | ||||||||
| Debt | ||||||||
Debt current | ||||||||
Long-term debt | ||||||||
Deferred revenue | ||||||||
Other long-term liabilities | ||||||||
Net debt | ||||||||
| Cash flow | ||||||||
Cash from operating activities | ||||||||
CAPEX | ||||||||
Cash from investing activities | ||||||||
Cash from financing activities | ||||||||
FCF | ||||||||
| Balance | ||||||||
Cash | ||||||||
Long term investments | ||||||||
Excess cash | ||||||||
Stockholders' equity | ||||||||
Invested Capital | ||||||||
ROIC | ||||||||
ROCE | ||||||||
| EV | ||||||||
Common stock shares outstanding | ||||||||
Price | ||||||||
Market cap | ||||||||
EV | ||||||||
EBITDA | ||||||||
EV/EBITDA | ||||||||
Interest | ||||||||
Interest/NOPBT | ||||||||